Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 18,000 shares at $17.72 ($319K) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $319k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |
| VNDA | SELL | 2020-08-14 | $85K | — | Filing → |